Skip to main content
. Author manuscript; available in PMC: 2019 May 15.
Published in final edited form as: J Immunol. 2018 Apr 9;200(10):3353–3363. doi: 10.4049/jimmunol.1701652

Figure 5. HLA-B*39:06Hom mice display increased diabetes development in the context of reduced thymic insulin expression.

Figure 5

(A) The results of diabetes incidence studies performed at Albert Einstein College of Medicine using female NOD.HLA-B*39:06Hom.β2mKO mice (n = 9) and their Ins2Het (n = 14) and Ins2KO (n = 9) counterparts are shown; p values are indicated (Mantel-Cox). (B) The ages at onset for all mice in (A) that became diabetic during the incidence study are plotted. Each circle represents an individual mouse. Lines denote mean ± SEM; p values are indicated (Mann-Whitney). Ins2WT, n = 3; Ins2Het, n = 11; Ins2KO, n = 9.